Product Information
DECONEX IR 385-10 MG TABLET is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6622 per EA under NDC 50991073690. Its NADAC has been published 330 times since Mar 22, 2017.
Strength
385; 10 mg/1; mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991073690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/8/2016
Pharmacological Classes
Price Statistics
The NADAC for DECONEX IR 385-10 MG TABLET has been published 330 times since Mar 22, 2017, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6622 per EA |
|---|---|
| All-time high | $0.7080 (Mar 14, 2018) |
| All-time low | $0.5988 (Mar 22, 2017) |
| 52-week high | $0.6622 |
| 52-week low | $0.6622 |
| Median price | $0.6160 |
| Average price | $0.6287 |
| Largest weekly change | +15.7% (Feb 21, 2018) |
| Weeks tracked | 330 |
| Tracking since | Mar 22, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+7.5%
5Y
+7.5%
All
+10.6%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Guaifenesin and Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin and Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DECONEX IR 385-10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DECONEX IR 385-10 MG TABLET, manufactured by Poly Pharmaceuticals, Inc., is $0.6622 per EA (NDC 50991073690), effective Feb 11, 2026.
How has the price of DECONEX IR 385-10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DECONEX IR 385-10 MG TABLET has risen 10.6%. It has been tracked across 330 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for DECONEX IR 385-10 MG TABLET?
Since Mar 22, 2017, the NADAC for DECONEX IR 385-10 MG TABLET has ranged from a low of $0.5988 (Mar 22, 2017) to a high of $0.7080 (Mar 14, 2018), with a median of $0.6160 per EA.
Are there cheaper alternatives to DECONEX IR 385-10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DECONEX IR 385-10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DECONEX IR 385-10 MG TABLET?
DECONEX IR 385-10 MG TABLET (NDC 50991073690) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.